Evidence map›Paper›PMID 41346445›Full record

ArticleOpen forum infectious diseases2025

Prevalence of

Hannah Wang, Bethany Burns, Deborah Wilson, Kelly Marigney, David Plunkett, Vinh Dang, Marisa Tungsiripat, Daniel Rhoads

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Urology case reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hannah WangPathology and Laboratory Medicine Department, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-3712-9188
Bethany BurnsPathology and Laboratory Medicine Department, Cleveland Clinic, Cleveland, Ohio, USA.
Deborah WilsonPathology and Laboratory Medicine Department, Cleveland Clinic, Cleveland, Ohio, USA.
Kelly MarigneyPathology and Laboratory Medicine Department, Cleveland Clinic, Cleveland, Ohio, USA.
David PlunkettPathology and Laboratory Medicine Department, Cleveland Clinic, Cleveland, Ohio, USA.
Vinh DangDepartment of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA.
Marisa TungsiripatDepartment of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio, USA.
Daniel RhoadsPathology and Laboratory Medicine Department, Cleveland Clinic, Cleveland, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Meningococcal urethritis is recognized as an emerging disease. However, its contemporary prevalence is unknown, and no molecular diagnostic tests are commercially available. With the widespread transition to molecular methods for sexually transmitted infection screening, high-throughput well-validated molecular methods for Methods: We tested for Results: The overall prevalence (95% confidence interval) of Conclusions: Our molecular prevalence study revealed that meningococcal urethritis is likely underdiagnosed in Ohio men, with 1 case for every 4-11 men with urogenital gonorrhea. With further optimization and validation, molecular testing may become a viable diagnostic or surveillance method for meningococcal urethritis.

Indexed as

meningococcusNeisseria meningitidisnucleic acid amplification test (NAAT)polymerase chain reaction (PCR)urethritis

Identifiers

PMID41346445
PMCPMC12673848

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.